Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05013541
Other study ID # GREENGRC01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 10, 2021
Est. completion date September 30, 2021

Study information

Verified date February 2022
Source Pierre and Marie Curie University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Increasing knowledge on rectal motility and bladder-rectum cross-talk has been published in recent years. However, whether bladder filling factors during multichannel urodynamic studies affect rectal contraction (RC) parameters has not been studied. The primary aim of this study is to assess the impact of bladder filling and desire to void on rectal contraction amplitude or frequency. Secondary objectives are to determine any significant change in rectal parameters depending on clinical and urodynamic factors or treatment. All patients referred for urodynamic assessment and with studies positive for rectal contractions as defined by the international continence society (ICS) will be included. Abdominal pressure will be measured using a T-doc air charged abdominal catheter inserted 10 cm from the anal margin. Standardized urodynamic evaluation will be conducted following ICS guidelines. Mean amplitude, maximal amplitude (cmH20) and mean frequency of rectal contractions on all urodynamic studies will be visually measured on the recording software and compared depending on bladder sensation (First Desire to void (FDV), Strong Desire to Void (SDV) and filling volume (200ml, 400ml). Demographic data (age, sex, BMI), underlying neurological disease, clinical symptoms, and scores (Neurogenic Bladder Symptom Score, Bristol Score, Cleveland Score), urodynamic parameters and treatments will be collected. Time since last defecation and meal will also be collected. This prospective observational study will be conducted in a Neuro-Urology department of a French university hospital. All the patients included are referred for multichannel urodynamic assessment.


Description:

Studies have suggested multiple types of colonic motor patterns including rectal motor activity. This rectal activity has been described in conventional multichannel urodynamic studies and has been determined not be an artefact. Some studies have related this rectal activity to bladder dysfunction, an underlying neurological affection or old ageing. However, the significance of this rectal activity observed during urodynamic studies remains unclear. It has been suggested that rectal activity may be a marker for underlying conditions. On the other hand, rectal phasic contractions using conventional manometry have been described for decades and consecutively coined rectal motor activity, periodic rectal motor activity and rectal motor complex. Recent data using High Resolution Manometry reports retrograde propagating cyclic motor patterns occurring with a frequency of 2 to 6 events per minute. In this study 59% of retrograde CMPs initiated in the sigmoid colon and rectum in the postprandial period suggesting a mechanism to limit rectal filling. This supports Rao and al.'s theory of a rectosigmoid brake. Modifications of CMP have also been shown in pathology such as slow transit constipation and fecal incontinence although results are conflicting. Furthermore, rectum and bladder share a common embryological origin and innervation which has led in recent years to the development of the concept of a cross talk between rectum and bladder. Animal and human studies have assessed the effect of rectal distension on bladder sensation and motility. However, whether bladder filling factors affect rectal contraction parameters has not been specifically studied. The primary aim of this study is to assess if bladder sensation and filling volume have any significant effect on rectal contraction parameters such as amplitude or frequency. Secondary objectives are to determine any significant change in rectal parameters depending on clinical and urodynamic factors or treatment. This prospective observational study will be conducted in a Neuro-Urology department of a French university hospital. All the patients included are referred for multichannel urodynamic assessment to explore urinary disorders. All patients referred for urodynamic assessment will be screened. All patients with a recording of rectal contractions as defined by the international continence society (ICS) during the urodynamic study will be included. Rectal contraction identified by a first investigator will have to be confirmed by a second investigator to be included for further analysis. The ICS defines rectal contractions as: temporary phasic increases in abdominal pressure without synchronous change in vesical pressure resulting in negative deflections of detrusor pressure. Based on previously published studies, rectal contractions resulting in a more than 5 cmH20 change of abdominal pressure will be included for analysis. Abdominal pressure will be measured using a T-doc air charged abdominal catheter inserted 10 cm from the anal margin. Patients will be informed on the procedure prior to the exam. Filling of the bladder will be carried out in a semi-seated position. Patients will be asked to report need to void; FSF, First Desire to Void (FDV) and SDV. The following data will be collected: age, sex, body mass index, etiology of urinary disorders, type of urinary or bowel symptoms, use of treatment for urinary or bowel dysfunction, time of last meal, detrusor overactivity on urodynamics. Amplitude and frequency of rectal contractions will be measured individually on the software used for the urodynamic study. The amplitude of each contraction will be measured as the difference between the peak of the contraction wave and the baseline preceding each contraction. Mean and maximum amplitude will be compared between time samples depending on bladder sensation and filling volume. The frequency will be calculate as (number of contraction on the studied period)/(time of the studied period). Absence of contraction on a sample will be counted as a frequency of 0. The occurrence of at least 2 contractions over a time sample will be necessary in order for an average frequency to be calculated. Frequency of contractions will be compared between beginning of cystometry to first desire to void (FDV) and FDV to end of bladder filling. Secondary analysis to assess the impact of clinical and urodynamic data on rectal contraction parameters will be performed. All data will be collected and analyzed without any identifying information.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date September 30, 2021
Est. primary completion date August 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - age over 18 - lower urinary tract dysfunction requiring cystometry assessement - rectal contraction during cystometry Exclusion Criteria: - Colo-rectal inflammatory or oncological disease - History of colo-rectal surgery - Irritable bowel syndrome - Probe expulsion (during urodynamic study).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
Observational study, standard record of need to void during cystometry

Locations

Country Name City State
France department of Neuro-Urology, Hôpital Teno Paris

Sponsors (1)

Lead Sponsor Collaborator
Gérard Amarenco

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Variation of the amplitude of rectal contraction function of bladder sensation 1 Difference of mean amplitude of rectal contraction between beginning of cystometry to first desire to void (FDV) and FDV to end of bladder filling (maximal capacity) One day
Secondary Variation of the amplitude of rectal contraction function of bladder sensation 2 Difference of mean amplitude of rectal contraction between beginning of cystometry to first desire to void (FDV) and FDV to Strong Desire to Void (SDV) one day
Secondary Variation of the amplitude of rectal contraction function of bladder sensation 3 Difference of maximal amplitude of rectal contraction between beginning of cystometry to first desire to void (FDV) and FDV to end of bladder filling (maximal capacity) One day
Secondary Variation of the amplitude of rectal contraction function of bladder sensation 4 Difference of maximal amplitude of rectal contraction between beginning of cystometry to first desire to void (FDV) and FDV to Strong Desire to Void (SDV) One day
Secondary Frequency of rectal contraction function of bladder sensation Difference of mean frequency of rectal contraction between beginning of cystometry to first desire to void (FDV) and FDV to end of bladder filling One day
Secondary Variation of the amplitude of rectal contraction function of bladder filling Difference of mean amplitude of rectal contraction between beginning of cystometry to 200mL of bladder filling and 200 to 400mL of bladder filling (maximal capacity) One day
Secondary Rectal contraction parameters function of patients' characteristics Difference of rectal contraction parameters (Mean amplitude, maximal amplitude and frequency) depending on demographic data (age, sex, BMI), underlying neurological disease, clinical symptoms, urodynamic status and treatments. One day
See also
  Status Clinical Trial Phase
Withdrawn NCT00713921 - Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients Early Phase 1
Withdrawn NCT00472784 - Quantitative and Qualitative Changes in Neural Efferent Receptors
Completed NCT04528784 - Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis N/A
Completed NCT02910596 - Effectiveness of Bethanechol Chloride and Early Bladder Training for Prevention of Bladder Dysfunction After Radical Hysterectomy in Cervical Cancer Stage IB - IIA Phase 4
Terminated NCT00688948 - Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS) Phase 2/Phase 3
Completed NCT05858840 - Urinary Artificial Sphincter in Children
Recruiting NCT05968352 - Restoration of Bladder Function in Spinal Cord Injury
Recruiting NCT05462561 - Vascularized Composite Bladder Allograft Transplantation N/A
Recruiting NCT04993859 - Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Recruiting NCT04626167 - Concomitant Renal and Urinary Bladder Allograft Transplantation Early Phase 1
Completed NCT03570593 - Removal of Urinary Catheter After Radical Surgery N/A
Active, not recruiting NCT04490642 - Linguistic Validation of the Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ) for 5-12 Years Old in Korean
Completed NCT04057222 - Effect of Need to Void on Rectal Sensory Function in Multiple Sclerosis
Not yet recruiting NCT06439862 - Study of the Quality of Life in School Aged-children With Posterior Urethral Valves
Recruiting NCT04835766 - Urodynamic Changes Following Bladder Injury
Completed NCT05351138 - Comparison of Transcutaneous Electrical Nerve Stimulation and Manual Therapy in Children With Cerebral Palsy N/A
Completed NCT03987126 - Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction Phase 3
Completed NCT01460303 - Patient-operated Valved Catheter Versus Indwelling Transurethral Catheter N/A
Completed NCT00280592 - Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients Phase 3
Completed NCT05861011 - Bladder Neck Surgery in Children With Neurogenic Bladder